Clinical Trial

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

Study acronym: STEPS A
Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the safety and performance of Silimed® silicone gel breast implants with a textured surface and Silimed® silicone gel breast implants with polyurethane coated surface. Female patients who underwent primary or secondary breast augmentation using Silimed® breast implants will be followed-up through 10 years. The safety of each type of Silimed® breast implant is going to be assessed by estimating the known and unexpected short- and long-term risk / adverse event rates. The performance of each type of Silimed® breast implant is going to be assesses by estimating the satisfaction and quality of life after implantation.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-11-22; most recent amendment 2026-03-12.
Status change: Not Yet Recruiting → Recruiting 2018-08-10
Trial Details
NCT Number NCT03356132
Lead Sponsor Silimed Industria de Implantes Ltda
Conditions Breast Implant; Complications, Quality of Life, Satisfaction
Enrollment 632 participants
Start Date 2018-07-31
Primary Completion 2036-12 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-16